Laxative Final Monograph To Include Drug Interaction Warning
This article was originally published in The Tan Sheet
Executive Summary
The OTC laxative final monograph will require a pre-cautionary drug-laxative interaction warning statement to be used in the labeling of all laxative products.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning